Cepizon-T 1.125G Injection
Marketer
Strathspey Labs Pvt Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Cepizon-T 1.125G Injection
Combiflox-1125mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be solely under medical guidance. Complete the prescribed dosage regimen, even with symptom improvement. Common reactions include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site inflammation (redness, swelling, pain) which typically resolve spontaneously. Severe or persistent side effects warrant immediate medical attention. Allergic responses (skin reactions, itching, swelling, respiratory distress) require prompt emergency care. Inform your physician of all current medications, including those for pre-existing conditions, prior to commencing treatment. Expectant and lactating mothers should consult their doctor before use. Alcohol consumption should be avoided due to potential for increased drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if experiencing somnolence or dizziness.
Uses of Cepizon-T 1.125G Injection
Infections caused by bacteria
Major Benefits of Cepizon-T 1.125G Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cepizon-T 1.125G Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Cepizon-T 1.125G Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Cepizon-T 1.125G Injection works:
Cepizon-T 1.125G Injection merges Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial enzymes that would otherwise neutralize Cefepime, thus broadening Cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while receiving Cepizon-T 1.125G Injection. Seek medical advice.
PregnancySAFE IF PRESCRIBED
The injectable medication Cepizon-T 1.125G is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; despite this, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can safely administer Cepizon-T 1.125G Injection. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Following administration of Cepizon-T 1.125G Injection, temporary visual blurring may occur. Refrain from driving until your vision has returned to normal.
KidneyCAUTION
Patients with impaired kidney function should receive Cepizon-T 1.125G Injection with careful monitoring. Dosage modification of Cepizon-T 1.125G Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Cepizon-T 1.125G Injection in individuals with hepatic impairment appears to pose minimal risk. Available evidence indicates that dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Cepizon-T 1.125G Injection :
Should you inadvertently skip a dose of Cepizon-T 1.125G Injection, seek medical advice.
Facts to Know About Cepizon-T 1.125G Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently